ESR1 and skin basal cell carcinoma: This observation is particularly interesting because examining the contribution of tumor-infiltrating leukocytes (TILs) to ER+BCC proliferation and response to endocrine therapy cannot be examined through the other available models to study ER+ tumor microenvironment.